Emerging evidence indicated that the increased expression of various pro-inflammatory factors in the striatum of rats with dyskinesia and the decrease of inflammatory mediators, such as TNF-α (13), COX-2 (38, 45), IL-1β (17) and iNOS (12, 46), could reduce the severity of LID. Here, IL1B is linked to drug-induced dyskinesia.